Locate your nearest distributor

Location:
Type:
Text search:
Username:
Password:
Forgot password?

News Archive

Biohit suspends trial aiming at H. pylori eviction

18.02.2014 10:45

 
Biohit suspends trial aiming at H. pylori eviction
 
 Biohit Oyj Stock Exchange Release February 18, 2014 at 10:45 am local time (EET)
 
A clinical study launched by Biohit to examine the ability of BioAcetium to help treat Helicobacter pylori infection has not produced clear-cut results. The BioAcetium Study has been suspended until further notice, whilst Biohit prioritizes other clinical studies.
 
The most essential reason for suspending the clinical study is the increased resistance of helicobacter strains to different therapies. The resistance to treatment by H. pylori strains varies geographically, which means that the treatment results in one country are not directly applicable elsewhere.
 
 
Stock Exchange Release February 18, 2014 (opens in a new window)